Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$1.44 - $2.73 $24,912 - $47,229
-17,300 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$2.63 - $3.67 $45,499 - $63,491
17,300 New
17,300 $46,000
Q4 2020

Feb 12, 2021

SELL
$2.09 - $3.09 $127,907 - $189,108
-61,200 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$2.39 - $3.43 $146,268 - $209,916
61,200 New
61,200 $154,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.